These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7011971)
61. Chemotactic and phagocytic responses of human alveolar macrophages to activated complement components. Richards SW; Peterson PK; Verbrugh HA; Nelson RD; Hammerschmidt DE; Hoidal JR Infect Immun; 1984 Feb; 43(2):775-8. PubMed ID: 6693176 [TBL] [Abstract][Full Text] [Related]
62. Opsonic activity of specific human IgG against Helicobacter pylori. Tosi MF; Czinn SJ J Infect Dis; 1990 Jul; 162(1):156-62. PubMed ID: 2355192 [TBL] [Abstract][Full Text] [Related]
63. Roles of antibody and complement in the bactericidal activity of mouse peritoneal exudate neutrophils. Hart PH; Spencer LK; Hill NL; McDonald PJ; Finlay-Jones JJ Br J Exp Pathol; 1987 Feb; 68(1):89-100. PubMed ID: 3545276 [TBL] [Abstract][Full Text] [Related]
64. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system. Kitamura H; Tsuboi M; Nagaki K Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147 [TBL] [Abstract][Full Text] [Related]
65. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Peterson PK; Kim Y; Wilkinson BJ; Schmeling D; Michael AF; Quie PG Infect Immun; 1978 Jun; 20(3):770-5. PubMed ID: 352958 [TBL] [Abstract][Full Text] [Related]
66. Assessment of the opsonic activity of purified bovine sIgA following intramammary immunization of cows with Staphylococcus aureus. Barrio MB; Rainard P; Gilbert FB; Poutrel B J Dairy Sci; 2003 Sep; 86(9):2884-94. PubMed ID: 14507024 [TBL] [Abstract][Full Text] [Related]
67. Release of leukotriene B4 from human neutrophils after interaction with nontypeable Haemophilus influenzae. Garofalo R; Faden H; Sharma S; Ogra PL Infect Immun; 1991 Nov; 59(11):4221-6. PubMed ID: 1657784 [TBL] [Abstract][Full Text] [Related]
68. Complement component C5 recruits neutrophils in the absence of C3 during respiratory infection with modified vaccinia virus Ankara. Price PJ; Bánki Z; Scheideler A; Stoiber H; Verschoor A; Sutter G; Lehmann MH J Immunol; 2015 Feb; 194(3):1164-8. PubMed ID: 25548218 [TBL] [Abstract][Full Text] [Related]
69. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors. Weis JJ; Law SK; Levine RP; Cleary PP J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574 [TBL] [Abstract][Full Text] [Related]
70. Antibacterial properties of breast milk: requirements for surface phagocytosis and chemiluminescence. Avery VM; Gordon DL Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1034-9. PubMed ID: 1802694 [TBL] [Abstract][Full Text] [Related]
71. Opsonins in uterine washings influencing in vitro activity of equine neutrophils. Watson ED Equine Vet J; 1988 Nov; 20(6):435-7. PubMed ID: 3063522 [TBL] [Abstract][Full Text] [Related]
72. Pasteurella haemolytica leukotoxin: chemiluminescent responses of peripheral blood leukocytes from several different mammalian species to leukotoxin- and opsonin-treated living and killed Pasteurella haemolytica and Staphylococcus aureus. Chang YF; Renshaw HW; Martens RJ; Livingston CW Am J Vet Res; 1986 Jan; 47(1):67-74. PubMed ID: 3946910 [TBL] [Abstract][Full Text] [Related]
73. Opsonophagocytosis of Pneumocystis carinii. Taylor MB; Phillips M; Easmon CS J Med Microbiol; 1992 Apr; 36(4):223-8. PubMed ID: 1560444 [TBL] [Abstract][Full Text] [Related]
74. Surface phagocytosis of Staphylococcus epidermidis and Escherichia coli by human neutrophils: serum requirements for opsonization and chemiluminescence. Gordon DL; Avery VM; Rice JL; McDonald PJ FEMS Microbiol Immunol; 1989 Dec; 1(8-9):417-23. PubMed ID: 2697319 [TBL] [Abstract][Full Text] [Related]
75. Opsonophagocytic activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement. Aase A; Michaelsen TE Scand J Immunol; 1994 Jun; 39(6):581-7. PubMed ID: 8009174 [TBL] [Abstract][Full Text] [Related]
76. New developments in immunopathology with special reference to complement and immune complexes. Frank MM Int Arch Allergy Appl Immunol; 1985; 77(1-2):89-95. PubMed ID: 3159688 [TBL] [Abstract][Full Text] [Related]
77. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. Clay CD; Soni S; Gunn JS; Schlesinger LS J Immunol; 2008 Oct; 181(8):5568-78. PubMed ID: 18832715 [TBL] [Abstract][Full Text] [Related]
78. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297 [TBL] [Abstract][Full Text] [Related]
79. Stimulation of polymorphonuclear leukocyte bactericidal activity by supernatants of activated human mononuclear cells. Cross AS; Lowell GH Infect Immun; 1978 Nov; 22(2):502-7. PubMed ID: 730369 [TBL] [Abstract][Full Text] [Related]
80. Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance. Blaser MJ; Smith PF; Repine JE; Joiner KA J Clin Invest; 1988 May; 81(5):1434-44. PubMed ID: 3366901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]